经超声诊断的子宫内膜异位症与接受首次体外受精/卵胞浆内单精子注射治疗女性较低的活产率相关
前瞻性观察性队列研究纳入1040例子宫内膜异位症不孕女性,首次IVF/ICSI前经阴道超声按IDEA标准诊断深部浸润型子宫内膜异位症(DIE)和/或子宫内膜瘤者234例(22.5%)。总累积活产率41.0%,DIE和/或子宫内膜瘤组33.3%低于无病组43.2%,校正后RR 0.63(95%CI 0.48-0.82)。
要点
- 首次IVF/ICSI前经阴道超声诊断DIE和/或子宫内膜瘤者累积活产率低于无病者。
- 两组获成熟卵母细胞数、受精率及优质胚胎数无差异。
- 校正年龄、BMI、AMH、刺激方案及移植日后,DIE和/或子宫内膜瘤与活产降低相关。
核心结论
- 经阴道超声诊断的DIE和/或子宫内膜瘤会降低首次IVF/ICSI治疗女性的活产机会。
研究设计与样本
- 前瞻性观察性队列研究,在大学医院进行,纳入2019年1月至2022年10月间接受首次IVF/ICSI治疗的1040例25至≤39岁不孕女性。
- 其中234例(22.5%;95%CI 20.0-25.0)在开始治疗前经系统经阴道超声诊断DIE和/或子宫内膜瘤。
- 所有女性接受首次IVF或ICSI治疗,使用第一周期的新鲜和/或冷冻胚胎直至妊娠或无可移植胚胎。
主要发现
- 总队列首次IVF/ICSI后累积活产率为426/1040(41.0%;95%CI 38.0-44.0)。
- DIE和/或子宫内膜瘤组累积活产率为78/234(33.3%;95%CI 27.3-39.4),低于无病组的348/806(43.2%;95%CI 39.8-46.6)。
- DIE和/或子宫内膜瘤组累积活产的粗相对风险(RR)为0.77(95%CI 0.63-0.94),校正年龄、体质指数、抗苗勒管激素、刺激方案及胚胎移植日后校正RR为0.63(95%CI 0.48-0.82)。
- 两组间获成熟卵母细胞数、受精率及优质胚胎数无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment in women with or without deep-infiltrating endometriosis (DIE) and/or endometrioma diagnosed by transvaginal ultrasonography (TVUS), using the International Deep Endometriosis Analysis (IDEA) group definitions. DESIGN: Prospective observational cohort study at a university hospital. PATIENTS(S): In total, 1,040 women with subfertility aged 25 to ≤39 years were undergoing their first IVF/ICSI treatment between January 2019 and October 2022. Of these, 234 (22.5%; 95% confidence interval [CI], 20.0-25.0) women were diagnosed with DIE and/or endometrioma at systematic TVUS before starting their treatment. INTERVENTION(S): All women underwent their first IVF or ICSI treatment. Fresh and/or frozen embryos from the first cycle were used until pregnancy was achieved or no embryos remained. MAIN OUTCOME MEASURE(S): Cumulative live birth rate after the first IVF/ICSI cycle in women with or without DIE and/or endometrioma. RESULT(S): The CLBR after the first IVF/ICSI treatment in the total cohort of women was 426/1,040 (41.0%; 95% CI, 38.0-44.0). Women with DIE and/or endometrioma had a lower CLBR (78/234, 33.3%; 95% CI, 27.3-39.4) than women without the disease (348/806, 43.2%; 95% CI, 39.8-46.6). The crude relative risk (RR) for cumulative live birth for women with DIE and/or endometrioma was 0.77; 95% CI, 0.63-0.94, and after adjustments were made for age, body mass index, s-antimüllerian hormone, stimulation protocol, and day for embryo transfer, the adjusted RR was 0.63; 95% CI, 0.48-0.82. There was no difference in the number of retrieved mature oocytes, fertilization rate, or good quality embryos between the 2 groups. CONCLUSION: The presence of DIE and/or endometrioma diagnosed by TVUS lowers the chance of live birth in women undergoing their first IVF/ICSI treatment.
引用
- Alson S, Henic E, Jokubkiene L, et al. Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment. Fertil Steril. 2024. PMID: 38246403. doi:10.1016/j.fertnstert.2024.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。